Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intensive hospital monitoring of adverse drug reactions for Shenmai Injection
ChiCTR-ONC-12002915Phase 4Completed
- Sponsor
- Institute of Basic Research in Clinical Medicine
- Start
- Jun 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of shenmai injection in Shock, sponsored by Institute of Basic Research in Clinical Medicine. Primary endpoint: Incidence of severe adverse drug reaction. Started Jun 2011; status: completed.
02
Drugs
shenmai injection
03
Conditions
Shock
Beyond the preview
Go deeper on ChiCTR-ONC-12002915.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-ONC-12002915.